Bibliographical noteFunding Information:
sources: BIOMAP has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 821511. The JU receives support from the European Union?s Horizon 2020 research and innovation programme and EFPIA. L.P. and J.L.M. work in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/5) and the University of Bristol.We would like to thank the following people who formed the BIOMAP Glossary Stakeholder Group and contributed to the development of the BIOMAP glossary: D. Aagaard-Hansen, A. Aguayo Orozco, I.A. Barbosa, K. B?nnelykke, N. Boraczynski, S.J. Brown, A. Budu-Aggrey, P. Bryce, S. Maria Christensen, J. Di Domizio, K. Dormanns, S. Eyerich, A. Farag, A. Federico, N. Forg?, V. Fortino, S. Gerdes, M. Gilliet, M. Gossel, D. Greco, M. Griffiths, B. Hinrichs, M. Hjelmsoe, N. H?jsgaard J?rgensen, B. Homey, Y. Kelkar, E. Kieras, S. Langan, T. Litman, W. Rush Koopmann, D. McKean, L. Moebus, L. Moitinho e Silva, A. Napieralski, P. Ol?h, K. Page, K. Polychronopoulos, M. Reiger, M. Rissetto, H. Sinkko, K. Skak, T. Skoog, M. Soverini, J. Stokholm, C. Traidl-Hoffmann, T. Traks, E. van den Bogaard and K. Vierlinger [full names and affiliations are available in Appendix S1 (see Supporting Information)].